CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 147 filers reported holding CONMED CORP in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,688,399 | -14.7% | 82,060 | -1.4% | 0.00% | 0.0% |
Q1 2024 | $6,666,099 | -26.1% | 83,243 | +1.1% | 0.00% | -33.3% |
Q4 2023 | $9,020,339 | +19.3% | 82,370 | +9.9% | 0.00% | 0.0% |
Q3 2023 | $7,558,405 | -11.6% | 74,947 | +19.2% | 0.00% | 0.0% |
Q2 2023 | $8,546,802 | +33.8% | 62,895 | +2.3% | 0.00% | 0.0% |
Q1 2023 | $6,385,832 | +9.2% | 61,485 | -6.8% | 0.00% | 0.0% |
Q4 2022 | $5,849,265 | +10.6% | 65,989 | +0.0% | 0.00% | 0.0% |
Q3 2022 | $5,289,000 | -45.0% | 65,972 | -34.4% | 0.00% | -25.0% |
Q2 2022 | $9,624,000 | -2.4% | 100,500 | +51.4% | 0.00% | 0.0% |
Q1 2022 | $9,858,000 | +2.1% | 66,360 | -2.6% | 0.00% | +33.3% |
Q4 2021 | $9,659,000 | +8.4% | 68,138 | +0.0% | 0.00% | -25.0% |
Q3 2021 | $8,910,000 | -7.0% | 68,107 | -2.3% | 0.00% | 0.0% |
Q2 2021 | $9,578,000 | +7.6% | 69,696 | +2.2% | 0.00% | 0.0% |
Q1 2021 | $8,903,000 | +17.3% | 68,176 | +0.6% | 0.00% | 0.0% |
Q4 2020 | $7,590,000 | +70.9% | 67,766 | +20.0% | 0.00% | +100.0% |
Q3 2020 | $4,441,000 | -0.1% | 56,456 | -8.6% | 0.00% | -33.3% |
Q2 2020 | $4,444,000 | +25.6% | 61,737 | -0.1% | 0.00% | 0.0% |
Q1 2020 | $3,539,000 | -48.1% | 61,797 | +1.4% | 0.00% | -25.0% |
Q4 2019 | $6,816,000 | +16.7% | 60,947 | +0.3% | 0.00% | 0.0% |
Q3 2019 | $5,842,000 | -50.5% | 60,756 | -55.9% | 0.00% | -42.9% |
Q2 2019 | $11,796,000 | +13.4% | 137,847 | +10.2% | 0.01% | 0.0% |
Q1 2019 | $10,402,000 | +59.2% | 125,057 | +22.9% | 0.01% | +40.0% |
Q4 2018 | $6,533,000 | -23.6% | 101,757 | -5.7% | 0.01% | -16.7% |
Q3 2018 | $8,552,000 | -10.6% | 107,957 | -17.4% | 0.01% | -14.3% |
Q2 2018 | $9,565,000 | +24.2% | 130,672 | +7.5% | 0.01% | +16.7% |
Q1 2018 | $7,701,000 | +83.8% | 121,606 | +47.9% | 0.01% | +100.0% |
Q4 2017 | $4,191,000 | -9.3% | 82,227 | -6.6% | 0.00% | 0.0% |
Q3 2017 | $4,619,000 | +27.3% | 88,027 | +23.6% | 0.00% | 0.0% |
Q2 2017 | $3,628,000 | +81.3% | 71,227 | +58.0% | 0.00% | +50.0% |
Q1 2017 | $2,001,000 | +0.5% | 45,067 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $1,991,000 | +10.3% | 45,067 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $1,805,000 | -16.1% | 45,067 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $2,151,000 | +27.1% | 45,067 | +11.6% | 0.00% | +100.0% |
Q1 2016 | $1,693,000 | -8.4% | 40,367 | -3.8% | 0.00% | -50.0% |
Q4 2015 | $1,849,000 | -8.9% | 41,967 | -1.3% | 0.00% | 0.0% |
Q3 2015 | $2,030,000 | -18.1% | 42,517 | -0.1% | 0.00% | 0.0% |
Q2 2015 | $2,480,000 | +10.5% | 42,567 | -4.3% | 0.00% | 0.0% |
Q1 2015 | $2,245,000 | +12.3% | 44,467 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $1,999,000 | +22.0% | 44,467 | 0.0% | 0.00% | +100.0% |
Q3 2014 | $1,638,000 | -16.6% | 44,467 | 0.0% | 0.00% | -50.0% |
Q2 2014 | $1,963,000 | +1.6% | 44,467 | -0.1% | 0.00% | 0.0% |
Q1 2014 | $1,933,000 | +2.3% | 44,493 | +0.0% | 0.00% | 0.0% |
Q4 2013 | $1,890,000 | +2.1% | 44,482 | -18.3% | 0.00% | 0.0% |
Q3 2013 | $1,851,000 | +9.2% | 54,467 | +0.4% | 0.00% | 0.0% |
Q2 2013 | $1,695,000 | – | 54,272 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |